Trial completion date
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
ER positive • HER-2 negative • HER-2 negative + AR positive + ER positive • HER-2 negative + ER positive
|
carboplatin • albumin-bound paclitaxel • Zolinza (vorinostat)